Telemus Capital, LLC Abb Vie Inc. Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Telemus Capital, LLC holds 8,182 shares of ABBV stock, worth $1.47 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,182

Previous 8,213 0.38%

Holding current value

$1.47 Million

Previous $1.22 Million 3.51%

% of portfolio

0.11%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $4,265 - $4,804	-31 Reduced 0.38%	8,182 $1.27 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $714,172 - $826,758	-5,346 Reduced 39.43%	8,213 $1.22 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $207,643 - $258,398	-1,567 Reduced 10.36%	13,559 $1.83 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $195,946 - $225,661	-1,355 Reduced 8.22%	15,126 $2.41 Million
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $52,834 - $63,362	-382 Reduced 2.27%	16,481 $0
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $115,420 - $132,379	-860 Reduced 4.85%	16,863 $2.26 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $202,301 - $257,191	-1,470 Reduced 7.66%	17,723 $2.71 Million
Q1 2022 Apr 06, 2022	SELL	$131.98 - $163.75 $126,964 - $157,527	-962 Reduced 4.77%	19,193 $3.11 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $21,056 - $26,642	-196 Reduced 0.96%	20,155 $2.73 Million
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $798,319 - $906,212	-7,503 Reduced 26.94%	20,351 $2.2 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $2.76 Million - $3.08 Million	-26,258 Reduced 48.53%	27,854 $3.14 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $968,064 - $1.07 Million	9,463 Added 21.19%	54,112 $5.74 Million
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $9,819 - $13,257	122 Added 0.27%	44,649 $4.78 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $278,176 - $326,487	3,238 Added 7.84%	44,527 $3.84 Million
Q2 2020 Jul 17, 2020	SELL	$73.37 - $98.18 $586 - $785	-8 Reduced 0.02%	41,289 $4 Million
Q1 2020 Jun 05, 2020	BUY	$64.5 - $97.79 $153,961 - $233,424	2,387 Added 6.13%	41,297 $3.83 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $125,650 - $157,215	1,742 Added 4.69%	38,910 $3.45 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $47,927 - $57,622	-761 Reduced 2.01%	37,168 $2.81 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $49,603 - $63,404	-755 Reduced 1.95%	37,929 $2.47 Million
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $16,353 - $19,247	212 Added 0.55%	38,684 $3.12 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $700 - $864	9 Added 0.02%	38,472 $3.55 Million
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $3,823 - $4,250	43 Added 0.11%	38,463 $3.64 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $2,244 - $2,655	-25 Reduced 0.07%	38,420 $3.56 Million
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $40,760 - $54,582	-443 Reduced 1.14%	38,445 $3.64 Million
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $932,409 - $1.02 Million	10,411 Added 36.56%	38,888 $3.76 Million
Q3 2017 Nov 03, 2017	SELL	$69.85 - $89.22 $14,319 - $18,290	-205 Reduced 0.71%	28,477 $2.53 Million
Q2 2017 Apr 03, 2018	BUY	N/A	34 Added 0.12%	28,682 $2.08 Million
Q1 2017 Apr 03, 2018	BUY	N/A	28,648	28,648 $1.87 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Abb Vie Inc. Transaction History